Phaseline

Companies › Sano Chemicals

Sano Chemicals: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 2; Infectious disease; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
OCF001 Intravaginal Gel
Antifungal antibiotic
–Phase 2Candidiasis, VulvovaginalDec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07521137OCF001 Intravaginal GelPhase 2Candidiasis, VulvovaginalInfectious diseaseDec 2026

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Amplexd Therapeutics Hyundai Bioscience KTH Biopharma Frantz Viral Therapeutics Grand Theravac Life Sciences (Nanjing)

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.